SILK - Silk Road Medical, Inc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Silk Road Medical, Inc

1213 Innsbruck Drive
Sunnyvale, CA 94089
United States
408 720 9002

IndustryMedical Devices
Full Time Employees176

Key Executives

NameTitlePayExercisedYear Born
Ms. Erica J. RogersPres, CEO & Director944.91kN/A1964
Mr. Lucas W. BuchananChief Financial Officer755.78kN/A1978
Mr. Andrew S. DavisExec. VP of Global Sales & Marketing883.92kN/A1969
Mr. Robert A. NicholasVP of Operations & EngineeringN/AN/A1963
Ms. Alison HighlanderVP of HRN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.

Corporate Governance

Silk Road Medical, Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.